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Abstract
Background
Individuals with Lewy body Dementia (LBD), which encompasses both Parkinson disease
dementia (PDD) and Dementia with Lewy Bodies (DLB) experience functional decline
through Parkinsonism and sedentariness exacerbated by motor, psychiatric and cognitive
symptoms. Exercise may improve functional outcomes in Parkinson’s disease (PD), and
Alzheimer’s disease (AD). However, the multi-domain nature of the LBD cluster of symp-
toms (physical, cognitive, psychiatric, autonomic) results in vulnerable individuals often
being excluded from exercise studies evaluating physical function in PD or cognitive func-
tion in dementia to avoid confounding results. This review evaluated existing literature
reporting the effects of exercise interventions or physical activity (PA) exposure on cluster
symptoms in LBD.
Methods
A high-sensitivity search was executed across 19 databases. Full-length articles of any lan-
guage and quality, published or unpublished, that analysed effects of isolated exercise/
physical activity on indicative Dementia with Lewy Bodies or PD-dementia cohorts were
evaluated for outcomes inclusive of physical, cognitive, psychiatric, physiological and qual-
ity of life measures. The protocol for this review (Reg. #: CRD42015019002) is accessible
at http://www.crd.york.ac.uk/PROSPERO/.
Results
111,485 articles were initially retrieved; 288 full articles were reviewed and 89.6% subse-
quently deemed ineligible due to exclusion of participants with co-existence of dementia and
Parkinsonism. Five studies (1 uncontrolled trial, 1 randomized controlled trial and 3 case
reports) evaluating 16 participants were included. Interventions were diverse and outcome
PLOSONE | DOI:10.1371/journal.pone.0156520 June 3, 2016 1 / 18
a11111
OPEN ACCESS
Citation: Inskip M, Mavros Y, Sachdev PS, Fiatarone
Singh MA (2016) Exercise for Individuals with Lewy
Body Dementia: A Systematic Review. PLoS ONE
11(6): e0156520. doi:10.1371/journal.pone.0156520
Editor: Saravana Kumar, University of South
Australia, AUSTRALIA
Received: December 21, 2015
Accepted: May 16, 2016
Published: June 3, 2016
Copyright: © 2016 Inskip et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: The authors have no support or funding to
report.
Competing Interests: The authors have declared
that no competing interests exist.
homogeneity was low. Habitual gait speed outcomes were measured in 13 participants and
increased (0.18m/s, 95%CI -0.02, 0.38m/s), exceeding moderate important change (0.14m/
s) for PD cohorts. Other outcomes appeared to improve modestly in most participants.
Discussion
Scarce research investigating exercise in LBD exists. This review confirms exercise studies
in PD and dementia consistently exclude LBD participants. Results in this cohort must be
treated with caution until robustly designed, larger studies are commissioned to explore
exercise efficacy, feasibility and clinical relevance.
1. Introduction
The worldwide prevalence of dementia is estimated at 44 million people, and is expected to rise
to 135 million by 2050 [1]. The majority of dementia cases are attributable to Alzheimer’s disease
(AD) estimated at between 50–75% of all prevalence, followed by vascular dementia (20–30%)
[2]. However, a significant proportion of dementia cases are conservatively estimated to be attrib-
utable to Lewy body Dementia (LBD). The Lewy body dementias encompass both Parkinson’s
disease (PD) dementia (3–4%)[3] as well as dementia with Lewy bodies (DLB) (4–5%)[2,4].
The typical symptomology of LBD includes impaired memory, attention and executive
function, transient hallucinations and delusions, as well as distinct Parkinsonism, transient
losses of consciousness and Rapid eye movement Behaviour Sleep disorder (RBD) [5]. This
unique cluster of symptoms means that compared to other more common dementias and idio-
pathic PD, people with LBD often have a more rapid disease progression, greater rate of hospi-
tal admission [6], double the levels of depression [7], and functional decline [8], higher risk of
falls [9], higher rates of cognitive fluctuations [10], more visual perception issues [10], lesser
quality of life [11], and shorter survival time post-diagnosis [12]. The institutional care of peo-
ple with LBD has been estimated to be 60% more expensive than for people diagnosed with
AD, due predominantly to higher rates of hospitalization [13].
Current treatments for LBD are predominantly pharmacological with a mixture of medica-
tions such as acetylcholine-esterase inhibitors (cognitive management), antipsychotics (psy-
chosis management), and dopamine agonists (Parkinsonism management) employed with
mixed success [14]. Non-pharmacological treatments are most often occupational interven-
tions to minimize dysfunction in the home environment or physical therapy to improve gait.
Various modalities of exercise have been shown to be beneficial for cognitive and functional
outcomes (e.g. gait speed, walking endurance, multi-domain cognition) in dementia popula-
tions [15], while also benefiting function (e.g. walking endurance, mobility, and disability) in
PD populations [16]. Exercise is often recommended in LBD as well [14], but appears to be
included not based on any specific research in this cohort, but rather due to its benefits in these
other cohorts. The current gap in evidence stems from an exclusion of LBD populations from
both dementia and PD exercise trials, presumably due to their multi-domain cluster of symp-
toms [17]. Cognitive impairments are a common reason for exclusion from PD trials, while
physical impairments are a common reason for exclusion from dementia studies.
Therefore, the aim of this review was to retrieve any studies that explored the effect of exer-
cise or physical activity on individuals with LBD in relation to a variety of outcomes including
but not limited to physical, cognitive, psychiatric, physiological and quality of life measures, in
order to identify the quantity and quality of the existing evidence base. These results will
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identify gaps in the literature, which may direct the focus of future robust investigations and
clinical practice.
2. Methods
The protocol for this review is accessible with registration number (CRD42015019002) at
http://www.crd.york.ac.uk/PROSPERO/.
2.1 Eligibility criteria
Study design. Full-length studies of any design and quality, published or unpublished, and
of any language were considered.
Population. Human participants of any age with DLB or PDD were eligible, including PD
participants with cognitive scores that were indicative of dementia (MMSE<24) but had no
reported diagnosis in the study. Animal studies were not included.
Intervention. Studies evaluating the isolated effect of exercise (activity prescribed at an
effort above activities of daily living to improve wellbeing such as running) or physical activity
(low intensity, incidental activity with primary purpose other than improving wellbeing such
as cleaning) on any outcome in LBD were included. An intervention could be acute (applied
for only one session) or chronic (multiple sessions) but must have been applied separately to
outcome testing (i.e. a test of walking endurance could not in itself be an intervention). There
were no other restrictions.
Comparator and outcome restrictions. None applied in order to minimize risk of exclud-
ing studies using atypical terminology for outcomes and comparators.
2.2 Database search and strategy
The systematic search was conducted across a wide variety of databases by the primary author
(MI), including:
MEDLINE (1946-Current), Premedline, AMED (1985-February, 2015), PSYC info
(1806-Current), All EBM review databases [e.g. Cochrane database of systematic reviews
(2005-December 2014), ACP journal club (1991–January 2015), Database of Abstracts of
reviews of effects (1st-quarter 2015), Cochrane central register of controlled trials (January
2015), Cochrane Methodology register (3rd-Quarter 2012), Health technology assessment (1st-
quarter 2015), and NHS economic evaluation (1st-quarter 2015)], CINAHL (1981-present),
SportsDiscuss (1800-present), Ageline (1966–present), EMBASE (1947-present), Web of Sci-
ence (MEDLINE entries excluded,1900-current), PEDro (1929–present), ALOIS, Google
scholar (100 most relevant samples, 2013-current)
The high-sensitivity search included only ‘Population’ and ‘Intervention’ terms (see S1
Table for strategy) and was simplified when necessary in restricted databases (i.e. Google
scholar, PEDro). Email alerts were set up on the major databases after the initial search (28/01/
2015) and updated weekly until the last search (28/09/15). The reference lists of relevant review
articles were searched for potential articles.
In addition to academic literature databases, a simple stand-alone search engine (Google)
and embedded website search engine (Lewy body dementia America (LBDA), Lewy body soci-
ety UK) were searched weekly throughout the review process to search for lay articles referenc-
ing literature.
2.3 Study selection
The screening process (conducted by primary author M.I) was sequenced as below:
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1. Duplicates were removed through reference management (Endnote X7) software
2. Exclusion by title
3. Exclusion by abstract
4. Full text articles that were deemed ineligible were excluded
5. Full text articles classified as in-doubt or deemed eligible by primary author were reviewed
by author (YM) and author (MFS) with subsequent eligible articles included for review.
2.4 Data extraction
Data were extracted and analysed for each eligible study by primary author (MI) using pilot
tested data forms, adapted for all study designs. A second reviewer (YM) verified the extracted
data and subsequent analysis, and any discrepancies in chosen data or analysis were reviewed
and resolved prior to tabulation by third reviewer (MFS). Data were extracted at the level of
each study (aggregate) and where relevant as individual subject data.
Categories of data were extracted as follows:
1. Study design: Studies were defined as experimental (randomized and nonrandomized con-
trol trials (RCT and NRCT), uncontrolled trial (UCT), or case-control) or observational
(cross-sectional, prospective or retrospective cohort, case reports, case series) design. Infor-
mation related to the quality assessment of controlled trials was also collected to complete
the Physiotherapy Evidence Database (PEDro) scale criteria. Data collection of observa-
tional studies was conducted to enable description as per the Strengthening the Reporting of
Observational studies in Epidemiology (STROBE) consensus statement [18] or the Case
report (CARE) checklist for case reports [19].
2. Intervention or exposure: exercise modality, volume, frequency, intensity, progression, and
duration of program, or in the case of epidemiological data, exposure to physical activity.
3. Cohort: age, sex, diagnosis, years since diagnosis, Mini-mental State Exam (MMSE)/cogni-
tive scores, Unified Parkinson’s Disease Rating Scale (UPDRS)/ mobility scores, co-morbid
diseases, medications for PD or dementia, weight/body mass index (BMI), community or
non-community dwelling.
4. Outcome: measurement tool or test used, mean and standard deviation (SD) at all time
points, effect sizes (ESs), confidence intervals (CIs), mean differences between groups, statis-
tical tests over time and between groups, if available. Where possible, ESs and CIs were calcu-
lated from extracted data for each outcome within each study where not provided by authors.
Furthermore, data were collected on the number of PD trials and dementia trials in the
abstract and full text stage of the search that were found to be ineligible because they specifi-
cally excluded individuals with LBD.
2.5 Quality assessment
Quality and risk of bias in intervention trials were assessed with the PEDro scale [20]. Supervi-
sion of training interventions was added to the scale to further evaluate quality of the controlled
trials, but did not form part of the overall PEDro score. The STROBE checklist for observa-
tional studies was selected to assess epidemiological studies [18]. The CARE checklist [19] was
selected to assess case reports/case series. Study assessment tools were chosen to be specific to
the types of studies retrieved in order to evaluate the quality of each article within the context
of each type of study design. Authors MI and YM conducted the quality assessment of included
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literature, with a plan for any discrepancies in scoring to be resolved through discussion with
author MFS in order to reach a consensus. No such discrepancies occurred during this process.
2.6 Synthesis of results
A quantitative pooling of data (meta-analysis) was intended at the time of the search if appro-
priate, but not possible due to a lack of homogenous data and low quality of literature. Suffi-
cient homogenous data was defined as data being available for the minimum number of
participants needed to demonstrate similar effects in PD exercise studies with an alpha of 0.05
and a power of 0.8. A qualitative analysis was undertaken for this review. The groupings of
data based on the testing domains was analysed for general trends and direction of effect size to
be able to make comment on the efficacy of exercise reported in the limited number of partici-
pants in context of the bias and quality assessment of the scarce literature found. The authors
also considered data presented from similar cohorts (such as Parkinson’s disease, or other
dementias) in evaluating the effects of exercise in this cohort.
3. Results
3.1 Search results
Fig 1. illustrates the review process in the PRISMA format. The initial search retrieved 111,485
articles that were subjected to the eligibility criteria in the exclusion process. In total, 288 arti-
cles were reviewed in full and 283 excluded, with 89.6% of all full texts subsequently deemed
ineligible due to exclusion of participants for comorbidities of either dementia or Parkinson-
ism. Five articles were found eligible including an RCT [21], an UCT [22], and three case
reports [23–25], of which two were published. The data analysed in the RCT were a subset
(n = 4 participants with PD-dementia) among the 170 participants with dementia in the
cohort, accessed with freely available data [21] and assistance from the corresponding author
(E.W.T). The last case report [24] was identified in the search process as a poster and after con-
sultation with the corresponding author (C.D) the full, unpublished thesis was attained for
analysis [26].
3.2 Quality of included literature
The articles were evaluated with either the PEDro criteria [20] (trials) or the CARE criteria
[19] (case reports). The RCT by Telenius and colleagues [21] earned a moderate score (5/10)
and the UCT by Rochester and colleagues [22] was awarded a poor score (3/10) using the
PEDro tool (Table 1). Biases that were common between both of trials included a lack of blind-
ing of the participant and of the therapist. The nature of exercise trials makes it difficult for
blinding of therapists due to safety and ethical concerns surrounding professional training
regarding interventions, difficulty blinding a visible treatment of a prolonged duration, and
duty of care to the participant. This does present the possibility that therapists invested more
effort in the active arm and less in the control arm possibly leading to detection bias. The RCT
by Telenius and colleagues [21] did not report any attempt to ascertain whether participants
knew which intervention was the supposed active arm and which was the control, meaning
that in a population where motivation and mood fluctuates frequently participant adherence to
the intervention could have been affected. An additional measure added to the quality assess-
ment but not included in overall score PEDro score (out of 10), was supervision of exercise ses-
sions. Health professionals supervised both trials during intervention sessions.
The case reports by Dawley [26], Ciro and colleagues [23], and Tabak and colleagues [25]
were evaluated with the CARE checklist (Table 2) and all included the majority of essential
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Fig 1. PRISMA flow chart of search.
doi:10.1371/journal.pone.0156520.g001
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information outlined in the checklist. Elements often not reported were perspectives from the
participants and diagnostic challenges. The only item that all three case reports did not satisfy
was the provision of the patient’s history organized as a timeline. This was not considered by
the authors to be a crucial component as history was evaluated in a multiple other areas of each
report. The quality of the case reports in comparison to CARE criteria was quite high, although
the inherent nature of a case report structure means it is highly susceptible to a multitude of
biases. These include selection, detection and reporting biases that all arise from the clinical
nature of case reports. Achieving set criteria for rehabilitation of a participant within a specific
healthcare system rather than a research setting has the potential to cause the therapists to
exaggerate treatment outcomes. This can skew the perceived benefit of a therapy when the out-
comes of multiple case reports are evaluated together.
3.3 Demographic variables
A total of 16 participants (n = 2 controls) were included for analysis (Table 3), consisting of 2/
16 with DLB, 10/16 with PD-dementia, and 4/16 with PD with Mild Cognitive Impairment
(MCI) that could not be isolated from the dementia cohort in Rochester and colleagues [22].
Mean age was 62 years (57–98 yrs) and the majority (12/16) of the participants were male. Cog-
nitive screening scores were reported as both MMSE [27] scores (n = 14, range 6-26/30) and a
Montreal Cognitive Assessment (MoCA) [28] score (n = 1, 17/30). All participants were com-
munity dwelling except the participants in Telenius and colleagues [21] (n = 4) who resided in
a nursing home. Time since diagnosis of dementia was only reported in the three case reports
[23,25,26] and ranged from at the time of screening (0 yrs) up to 2 yrs. Rochester and
Table 1. PEDro score: Experimental studies.
Criteria Study
Telenius et al
2015
Rochester et al.
2009
1. Eligibility criteria were specified YES YES
2. Subjects were randomly allocated to groups (in a crossover
study, subjects were randomly allocated an order in which
treatments were received)
YES NO
3. Allocation was concealed YES NO
4. The groups were similar at baseline regarding the most important
prognostic indicators
NO NO
5. There was blinding of all subjects NO NO
6. There was blinding of all therapists who administered the therapy NO NO
7. There was blinding of all assessors who measured at least one
key outcome
YES NO
8. Measures of at least one key outcome were obtained from more
than 85% of the subjects initially allocated to groups
YES YES
9. All subjects for whom outcome measures were available received
the treatment or control condition as allocated or, where this was not
the case, data for at least one key outcome was analysed by
“intention to treat”
YES YES
10. The results of between-group statistical comparisons are
reported for at least one key outcome
NO NO
11. The study provides both point measures and measures of
variability for at least one key outcome
NO NO
TOTAL PEDRO SCORE 5/10 3/10
12. Exercise intervention was supervised Yes Yes
doi:10.1371/journal.pone.0156520.t001
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colleagues [22] reported a mean time since diagnosis of PD only (not dementia diagnosis) as 6
yrs. Most trials reported participant use of neuropsychological medications except the UCT by
Rochester and colleagues [22]. There was limited presentation of participant characteristics
such as co-morbidities and psychological health, and nutritional status, metabolic health mark-
ers, body composition and habitual physical activity levels were searched for explicitly but not
reported in any study.
Table 2. CARE Criteria: Case report studies.
Criteria Study
Ciro et al.
2013
Tabak et al
2013
Dawley
2014
Title 1. The words ‘‘case report’ should appear in the title along with the area of
focus
N Y Y
Key words 2. 2 to 5 key words that identify areas covered in this case report Y Y N
Abstract 3a. Introduction—what is unique about this case? What does it add to the
literature
Y Y Y
3b. The main symptoms of the patient and important clinical findings N Y Y
3c. The main diagnosis, therapeutic interventions and outcomes Y Y Y
3d. Conclusion—what are the main ‘take-away’ lessons from this case Y Y Y
Introduction 4. One or two paragraphs summarizing why this case is unique with
references
Y Y Y
Patient information 5a. De-identified demographic information and other patient specific
information
Y Y Y
5b. Main concerns and symptoms of the patients Y Y Y
5c. Medical, family and psychosocial history including relevant genetic
information
Y Y Y
5d. Relevant past interventions and their outcomes Y Y Y
Clinical findings 6. Describe the relevant physical examination and other significant clinical
findings
Y Y Y
Timeline 7. Important information from the patient’s history organized as a timeline N N N
Diagnostic 8a. Diagnostic methods (such as PE, Laboratory testing, imaging, surveyed Y Y Y
Assessment 8b. Diagnostic challenges (such as access, financial, or cultural) N N Y
8c. Diagnostic reasoning including other diagnosis considered N N Y
8d. Prognostic characteristics (such as staging in oncology) where applicable N N N
Therapeutic
intervention
9a. Types of intervention (such as pharmacologic, surgical, preventive, self-
care)
Y Y Y
9b. Administration of intervention (such as dosage, strength, duration) Y Y Y
9c. Changes in intervention (with rationale) Y Y Y
Follow-up and
outcome
10a. Clinician and patient assessed outcomes (when appropriate) Y Y Y
10b. Important follow up diagnostic and other results Y Y Y
10c. Intervention adherence and tolerability (how was this assessed) Y Y Y
10d. Adverse and unanticipated events Y N Y
Discussion 11a. Discussion of the strengths and limitations in your approach to this case Y Y Y
11b. Discussion of the relevant medical literature Y Y Y
11c. The rationale for conclusions (including assessment of possible causes) Y Y Y
11d. The primary ‘take-away’ lessons of this case report Y Y Y
Patient perspectives 12. When appropriate the patients share their perspective on the treatments
they received
N N N
Informed consent 13. Did the patient give informed consent? Please provide if requested Y Y Y
TOTAL CARE CHECKLIST SCORE (/30) 23 24 26
doi:10.1371/journal.pone.0156520.t002
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3.4 Baseline physical function characteristics
Baseline physical function is presented in Table 4. Habitual gait speed reported for 15/16 par-
ticipants ranged from 0.36–0.96 m/s (mean = 0.66 m/s, SD = 019 m/s). Maximal gait speed was
only reported in 4/16 participants and ranged from 0.49–1.1 m/s. Dual task gait speed (holding
a tray) was measured in 9/16 participants with a mean walking speed of 0.65 m/s. Walking dis-
tance was seldom recorded, with only one case report recording a six-minute walk distance of
430.86 m.
3.5 Intervention characteristics
Exercise interventions were varied and included verbal cueing with movement, motor training,
stationary cycling, large amplitude bodyweight exercise, high intensity functional exercises and
light leisure activities (control group, n = 2). The duration of sessions ranged from 1 to 180
mins, frequency ranged from once only to 5 times/week, and total program intervention ran-
ged from 1 session to 12 wks. The intensity was not reported in three studies, while the cycling
intervention reported 50–75% of heart rate maximum, and Telenius and colleagues [21] set a
target of performing a maximum of 12 repetitions of given weighted or body weight exercises.
Progression method ranged from increasing the complexity of the task to increasing the inten-
sity through velocity or load. Table 5 details the range of exercise interventions employed, with
a noticeable absence of interventions related to increasing incidental physical activity in daily
life.
3.7 Outcome measures
The data for the outcome measures discussed below is presented in Table 4. The most com-
monly reported outcomes were related to physical function measures. These measures were
grouped into gait speed, walking endurance, sit-to-stand function, balance and functional sta-
tus measures. Cognitive, psychiatric, quality of life and physiological measures were rarely
reported, and as such grouped into one category.
Gait speed. Habitual gait speed changes were reported in 15 participants across four stud-
ies (n = 2 participants in a control group). Habitual walking speed of exercise participants
(n = 13) increased by 0.18 m/s on average (95% CI -0.02, 0.38m/s).
Maximal walking speed was reported by Telenius and colleagues [21] in four participants
(n = 2 in a control group). Group size was insufficient for further statistical analysis.
Rochester and colleagues [22] reported change in dual task (holding a tray) walking speed
in 9 PD participants with a mixture of Parkinson’s disease dementia and MCI.
Walking endurance. Tests of walking endurance were reported in two case reports involv-
ing a total of two participants. Dawley [26] reported a significant post-intervention change in
walking distance of 82 m in the sole participant,.
Tabak and colleagues [25] reported considerable improvements in two-minute walking test
(2MWT) distance in one participant under single (28.9 m) and dual task conditions (42 m).
Sit-to-stand function. Standing function was reported for 6/16 participants across the two
case reports [23,26] and the RCT by Telenius and Colleagues (n = 4 participants) [21]. Single
chair stand function in Ciro and colleagues (23) improved in one participant using a custom-
ized rating scale of performance and satisfaction that was individualized for the participant.
Five participants were tested for multiple (30-second) chair stand ability (n = 2 in control
group). Those in the exercise groups (n = 3) performed a mean of 3 (range 2–4) more chair
stands in 30-seconds while those in the control group (range 0–1 stands) after training.
Balance function. Balance was measured through a range of scale and time measures in 6/
16 participants across two case reports and the RCT subset of Telenius and colleagues (21).
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The timed up & go (TUGT) and MiniBESTest [29] were reported in one participant in the case
report by Dawley [26]. The participant improved TUGT by 6.4 seconds and improved 4 points
on the MiniBESTest.
The single participant in Tabak and colleagues [25] improved 10/30 points in the Functional
gait assessment [30]. 1 of 2 PDD participants allocated to the exercise intervention in Telenius
and colleagues [21] improved on the Berg Balance scale [31] by 4 points. The other exercise
participant and two control participants changed non-significantly (<1point).
Functional status. Basic Activities of Daily Living (ADLs) and Instrumental Activities of
Daily Living (IADLs) were reported in 6 participants across two case reports and the RCT by
Telenius and colleagues (n = 2 control participants) [21]. Change in the Barthel Index [32] in
Telenius and colleagues [21] was inconclusive due to incomplete data. Improvement was
reported in the G-code mobility measure [33] employed by Dawley [26], as well as the PDQ-39
[34] and UPDRS-II [35] employed in the case report by Tabak and Colleagues [25]. The
UPDRS-II score of the sole participant improved by 9 points.
Cognitive, psychiatric, quality of life and physiological outcomes. Outcome data were
only collected for neuropsychiatric outcomes in 2/5 studies (5 participants in total, n = 2 con-
trol). There was no homogeneity of outcomes for group analysis.
Tabak and colleagues [25] reported improvement in Color Trail Test condition times by
57.5% (condition 1), and 56.7% (condition 2) post intervention for the sole participant. The
Parkinson’s Disease Cognitive Rating Scale (PD-CRS) improved 15 points,. UPDRS-I subsec-
tion scores for mood and cognition improved considerably 15/16 points.
The RCT subset by Telenius and colleagues [21] reported MMSE scores, Cornell Scale for
Depression in Dementia, Quality of Life in Late Stage Dementia (QAULID) and Neuropsychi-
atric Inventory (NPI) outcomes following intervention. Data for MMSE was incomplete there-
fore not analyzed, while data for the NPI, Cornell Scale for Depression in Dementia, and
QUALID was mixed between groups with incomplete, or non-significant changes.
Table 5. Intervention Characteristics. NR—Not reported.
Citation Exercise Modality Frequency
(sessions/
wk.)
Session/
stimulus
duration
(minutes)
Program
Duration
(wk)
Volume
(frequency x
duration)
minutes/wk.
Intensity
target
Progression
Rochester
et al. 2009
Acute verbal cueing
+ walking intervals
1 session only 1 B 1 session ~1 NR No progression
Ciro et al.
2013
STOMP (skill building
through task orientated
motor practice)
5 120–180 2 600–900 NR Increasing complexity
of task as appropriate
Tabak et al
2013
Stationary cycling 3 40 8 120 50%-75%
Heart rate
max
5% increase (% heart
rate max) in intensity/
week
Dawley,
2014
LVST BIG (Lee
Silverman voice
treatment—Big)
Intervention
0.66 A 55 12 36.6 A NR Increase in velocity
and movement
complexity as
appropriate
Telenius
et al 2015
High intensity functional
exercises (exercise
group), Light activity
(control group)
2 50–60 12 100–120 12RM load Increase to maintain
12RM intensity
A Average of 8 sessions over 3 months,
B Accumulated estimate of stimulus duration for trials, 12RM = 12 repetition maximum; the maximum amount of weight that can be lifted 12 times only
doi:10.1371/journal.pone.0156520.t005
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4. Discussion
The aim of this review was to search all available literature reporting the effects of exercise or
physical activity on individuals with LBD. Despite an exhaustive search, a total of only 16 par-
ticipants across five non-robust studies informed the conclusions of this review. Notably, 288
full articles were reviewed and 89.6% subsequently deemed ineligible due to exclusion of partic-
ipants with co-existence of dementia and Parkinsonism. The dearth of literature increased the
difficulty of analysis for the effect of exercise due to small, uncontrolled samples, as well as
highlighting the need for higher quality, larger scale research in the LBD population.
The functional capacity of Lewy body dementia participants within the studies is reported
to be relatively low in comparison with other similar cohorts. Average habitual gait speed was
0.66 m/s, which was significantly lower than those reported in another LBD cohort of 0.9 m/s
[36] and PD cohorts of 1.18 m/s [37]. Furthermore, average dual tasking walking speed was
reported in the results to be 0.65 m/s, which was significantly lower than speeds reported in PD
populations of 0.97 m/s [38]. The cut off for increased mortality, mobility, disability with activ-
ities of daily living, hospitalization and increased dementia risk in geriatric populations is
reported as 1.0 m/s [39]. The slower average gait speeds reported in this review fall below this
cut off and should be of concern to clinicians as it indicates a trend towards frailty and
increased medical complications in this cohort of individuals with LBD.
Despite the low levels of functional capacity, a promising sign in this small and highly varied
cohort is the improvements reported in predominantly functional outcomes upon application
of an exercise intervention. While the results must be treated with caution due to the low num-
ber of participants able to be evaluated and the highly biased study design formats, the review
found examples evidence of significant changes in function after exercise. Not all outcomes
had comparable data in the literature for expected improvements based on a similar cohort
(such as Parkinson’s disease), especially in the cognitive, psychiatric, quality of life and physio-
logical outcomes. There was however some notable improvements in function noted below by
this review.
Three studies reported participants improving in gait speed beyond the reported minimally
clinical significant change in PD cohorts of 0.06 m/s, and even beyond the moderate clinical
significant change of 0.14 m/s [40].
Single case reports demonstrated individually meaningful changes after intervention. The
sole participant in the case report of Dawley [26] improved 82m in the six-minute walk test
which exceeded minimal and moderate clinically significant changes in geriatric populations of
20-50m [41] and equaled the minimal change that can be reliably detected in PD cohorts [37].
Furthermore, the participant improved on the timed up and go test by 6.4 seconds which
exceeded the minimal change reliably detectable in PD cohorts (3.5–4.8 seconds [42,43]). The
participant in the case report by Tabak and colleagues [25] significantly exceeded the large
important clinical change for the daily activities subsection of the UPDRS (section-II) of 4.3–
4.6 points [44] by improving by 9 points following exercise.
No previous reviews of exercise in LBD exist to our knowledge. Other literature supports
the preliminary findings in LBD above, and has established the effectiveness of exercise in pop-
ulations that have similar symptoms to LBD, such as PD and non-motor dementias. For exam-
ple, exercise has an ES ranging from 0.5 to 2 [15] for outcomes including cognition, function,
fitness and strength in dementia cohorts, while PD studies report a mean ES of 0.47 for func-
tional outcomes [16]. Logically, it is reasonable to theorize that exercise may have similar
effects on LBD populations who report both dementia and Parkinsonian symptoms, but the
existing literature is insufficient to establish ESs with confidence. Conversely, it is possible that
the complexity of co-existing cognitive and motor impairments would make exercise too
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difficult to implement or minimize its efficacy in LBD. Until robust RCTs are conducted in suf-
ficiently powered trials, no firm conclusions can be drawn in this regard.
4.1 Strengths of this review
This is the first review of exercise in LBD. It was rigorously executed across 19 reputable data-
bases and was continually updated over a period of eight months through RSS and email search
updates. All types of full-length articles in any language were reviewed regardless of publication
status. Authors of included and excluded papers were contacted for additional data or informa-
tion if warranted, which ensured all available information on LBD cohorts could be included in
the review.
The review protocol was registered prospectively with PROSPERO (CRD42015019002) and
conformed to PRISMA guidelines in all applicable areas [45].
4.2 Limitations of this review
A limitation of the methodology in this review was the use of only the primary author to con-
duct the searches up to the final stage of full article review and analysis.
The scarce and low-quality literature available for analysis has been identified as a limiting
factor for any reported conclusions in this review despite the comprehensive search strategy
conducted by the authors.
4.3 Conclusion
The effect of exercise in individuals with LBD was evaluated in this review. The limited data
available in small, uncontrolled studies suggest further research in larger cohorts needs to be
conducted to evaluate any benefits reported in this small amalgamated group of individuals
with LBD before any judgments about the efficacy of exercise can be made. The effect of exer-
cise on other outcomes measured in this review including cognition, psychiatric, quality of life
and physiological outcomes remain unclear. A crucial finding of this review is that the over-
whelming majority of literature in related populations excludes LBD individuals from research
studies due to a cluster of symptoms that is multi-domain and seen to be confounding to
research data.
Exercise prescription is an intervention that requires not only sustained physical exertion
but also cognitive engagement. The implementation of exercise in a LBD cohort may be a task
that is complicated by a cognitive impairment coupled with physical symptoms of Parkinson-
ism and autonomic concerns such as orthostatic hypotension. An intervention in this cohort
needs to be tactful in the delivery of exercise, as the benefits demonstrated with various exercise
intervention in PD cohorts may not be transferable to LBD cohorts if cognition is limiting the
drive, engagement or comprehension of participants. Similarly, benefits of various exercise
interventions in other dementias such as ADmay not be feasible in a LBD cohort with Parkin-
sonism limiting speed, amplitude, length and complexity of movement. An exercise interven-
tion similar to those seen in PD cohorts used to target the physicality of LBD, but delivered in a
dementia friendly format is likely to be the most viable modality to investigate in future
research.
This review highlights the importance and need for conducting controlled trials that are
preferably randomized, in larger sample sizes of LBD cohorts to reliably evaluate the efficacy,
feasibility and relevance of exercise in this vulnerable population.
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